UBS Securities analyst Howard Capek, who kept a "buy" rating on shares of HealthSouth Corp. after the hospital operator was accused of accounting fraud, resigned Wednesday after the brokerage firm said he broke a rule in 1999 banning employees from discussing the stock.
Capek had told an institutional investor in an e-mail that he "would not own a share" of HealthSouth after UBS started investment banking work for the company from June to September 1999, brokerage spokesman Mark Arena said.
